 Ramila
Philip, Ph.D.
Prior to forming Immunotope, Inc., Ramila Philip, Ph.D., was the Senior
Vice President of Protein Discovery at RHeoGene LLC, and before that was
head of Research, Product and Business Development at Argonex Pharmaceuticals
(a fully owned subsidiary of Upstate Group Inc.) and Vice President of
Product Development and Scientific Affairs at Upstate Inc. At Argonex
and Upstate, Dr. Philip developed proteomics platform technologies and
immunotherapy target discovery strategies. Dr. Philip also established
several collaborative protein discovery agreements while at Upstate.
Prior to Upstate, Dr. Philip was the Senior Director of Oncology and
Gene Therapy at Rhone Poulenc Rorer Gencell. Dr. Philip has developed
various immunotherapy and gene therapy products from research to early
phase clinical testing at RPR Gencell and Argonex. Prior to joining RPR
Gencell, Dr. Philip was an Assistant Research Immunologist at UCSF and
worked at the cancer research institute for six years.
Dr. Philip earned her Ph.D. in Immunology from India and did her postdoctoral
training at the Institute of Immunology, Basel, Switzerland. Dr. Philip
has over 15 years of experience in biotech industry and has developed
several biotherapeutic products. She has over 50 publications in national
scientific journals.
|
|
